#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4844594	B	Protac activity at CRBN/AR in human VCaP cells assessed as AR degradation after 24 hrs by Western blot analysis	Homo sapiens	40	ALA4842372	cell-based format	Scientific Literature
2.	ALA4844595	B	Protac activity at CRBN/AR in human VCaP cells assessed as maximal AR degradation after 24 hrs by Western blot analysis relative to control	Homo sapiens	40	ALA4842372	cell-based format	Scientific Literature
3.	ALA4844599	A	Half life in SCID mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
4.	ALA4844600	A	AUC (0 to t) in SCID mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
5.	ALA4844601	A	Volume of distribution at steady state in SCID mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
6.	ALA4844607	A	Tmax in SCID mouse at 5 mg/kg, po by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
7.	ALA4844608	A	Half life in SCID mouse at 5 mg/kg, po by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
8.	ALA4844609	A	Cmax in SCID mouse at 5 mg/kg, po by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
9.	ALA4844610	A	AUC (0 to t) in SCID mouse at 5 mg/kg, po by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
10.	ALA4844611	A	Oral bioavailability in SCID mouse at 5 mg/kg by LC-MS/MS analysis	Mus musculus	1	ALA4842372	organism-based format	Scientific Literature
11.	ALA4844612	F	Growth inhibition of human VCaP cells assessed as cell viability by WST-8 assay	Homo sapiens	22	ALA4842372	cell-based format	Scientific Literature
12.	ALA4844613	B	Protac activity at CRBN/AR T878A mutant in human LNCaP cells assessed as AR degradation after 24 hrs by Western blot analysis	Homo sapiens	8	ALA4842372	cell-based format	Scientific Literature
13.	ALA4844614	B	Protac activity at CRBN/AR T878A mutant in human LNCaP cells assessed as maximal AR degradation after 24 hrs by Western blot analysis relative to control	Homo sapiens	8	ALA4842372	cell-based format	Scientific Literature
14.	ALA4844615	F	Growth inhibition of human LNCaP cells carrying AR T878A mutant assessed as cell viability by WST-8 assay	Homo sapiens	8	ALA4842372	cell-based format	Scientific Literature
15.	ALA4844616	B	Protac activity at CRBN/AR in human VCaP cells assessed as reduction in AR protein level after 6 hrs by Western blot analysis relative to control	Homo sapiens	9	ALA4842372	cell-based format	Scientific Literature
16.	ALA4844617	B	Protac activity at CRBN/AR T878A mutant in human LNCaP cells assessed as reduction in AR protein level after 6 hrs by Western blot analysis relative to control	Homo sapiens	9	ALA4842372	cell-based format	Scientific Literature
17.	ALA4844618	B	Protac activity at CRBN/AR in human VCaP cells assessed as reduction in AR protein level after 24 hrs by Western blot analysis relative to control	Homo sapiens	9	ALA4842372	cell-based format	Scientific Literature
18.	ALA4844619	B	Protac activity at CRBN/AR T878A mutant in human LNCaP cells assessed as reduction in AR protein level after 24 hrs by Western blot analysis relative to control	Homo sapiens	9	ALA4842372	cell-based format	Scientific Literature
19.	ALA4844620	F	Antitumor activity against human VCaP cells xenografted in CB17:SCID mouse assessed as reduction in AR protein level in tumor at 20 mg/kg, po measured for 6 to 24 hrs by Western blot analysis	Homo sapiens	3	ALA4842372	organism-based format	Scientific Literature
20.	ALA4844621	A	Drug distribution in plasma of CB17:SCID mouse xenografted with human VCaP cells at 20 mg/kg, po measured at 6 hrs by LCMS analysis	Mus musculus	4	ALA4842372	organism-based format	Scientific Literature